All news from Immuno Haematology & Blood Transfusion
The researches shows that immune responses and undermine defence against infection, new research has found. The study, led by scientists at the University of Sheffield; therefore reveal that cells which are programme to die, a process know as apoptosis, can disrupt the normal function of immune cells; called macrophages. This impact on how well they…
The study find that immune system against cancer have made remarkable progress against certain types of tumors; therefore they still remain ineffective in most cancer patients. A new study from the Center for Immunology and Inflammatory Diseases (CIID) at Massachusetts General Hospital (MGH) describes a method of reprogramming the regulatory T cells that usually suppress…
The refreshers find that autoimmune diseases which can be seen on the body or felt through symptoms; the attack on the islets not be observe because they reside deep within the pancreas. Therefore Identifying a reliable biomarker to predict the onset of autoimmunity in type 1 diabetes (T1D) has eluded scientists. Because An immune system…
stem cells are protect from viruses inform the development of therapies for use in medicine; therefore research suggests. An immune system is a collection of biological processes within an organism that protects against disease by identifying and killing pathogens and tumour cells. Because It detects a wide variety of agents; therefore from viruses to parasitic…
The research shows that Multiple sclerosis (MS) is an autoimmune disease in which the immune system; turns on its win cells and attacks them for reasons that are not yet know. Scientists from the Institut Pasteur have show that ancient viruses are involve in the acute inflammatory defense response that may contribute to the disease.…
The defense system that usually protects patients from external aggression turns on its own cells ; and attacks them for reasons that are not know. Scientists from the Institut Pasteur have shown that ancient viruses are involve ; therefore in the acute inflammatory defense response that may contribute to the disease. Autoimmune diseases result from…
The Debilitating fatigue, a trademark ‘butterfly’ rash across the cheeks and nose, and the risk of kidney failure lupus is a severe disease where the patient’s immune system attacks their own organs and tissues. More than five million people worldwide are living with a form of lupus most are women; but men can carry the burden…
Mismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations; or changes, in certain genes when their mismatch repair proteins are unable to correct mistakes make when DNA is copied and pass on to daughter cells. Tumor cells with many such mutations create what is know as…
Johns Hopkins scientists report that adult cells reprogrammed to become primitive stem cells, called induced pluripotent stem cells (iPSCs), make tiny “cargo packets” able to deliver potentially restorative or repairing proteins, antibodies or other therapies to aged cells. Because They say the human iPSCs they studied produced much more of the packets, formally known as…
To kill bacteria in the blood, our immune system relies on nanomachines that can open deadly holes in their targets. UCL scientists have now filmed these nanomachines in action, discovering a key bottleneck in the process which helps to protect our own cells. The research, published in Nature Communications; provides us with a better understanding of how…
Scientists at Seattle Children’s Research Institute are paving the way to use gene-edited B cells a type of white blood cell in the immune system to treat a wide range of potential diseases that affect children; including hemophilia and other protein deficiency disorders; autoimmune diseases; and infectious diseases. If successful, their research would open the door…
Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In a promising development, researchers at Baylor College of Medicine released initial findings from the first two patients treated in a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using…